CAT-3000 series

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCAT-3000 series
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLipid Metabolism DisordersCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstria Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstria Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A